We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.49B
AUM Growth
-$343M
(-3.9%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-2.94%
Top 10 Holdings %
Top 10 Hldgs %
16.07%
Holding
2,271
New
51
Increased
125
Reduced
935
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.3M |
| 2 |
Baxter International
BAX
|
+$9.74M |
| 3 |
Archer Daniels Midland
ADM
|
+$6.88M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$6.54M |
| 5 |
Nektar Therapeutics
NKTR
|
+$4.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$17.1M |
| 2 |
Apple
AAPL
|
+$10.6M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$10.1M |
| 4 |
AvalonBay Communities
AVB
|
+$7.62M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$6.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.14% |
| 2 | Financials | 17.01% |
| 3 | Healthcare | 12.77% |
| 4 | Industrials | 11.29% |
| 5 | Consumer Discretionary | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Robert Half
RHI
$4.48B
| $2.17M | 0.03% |
37,395
-1,389
| -4% | -$79.4K |
|
|
TCO
752
DELISTED
Taubman Centers Inc.
TCO
| $2.16M | 0.03% |
38,010
-404
| -1% | -$24.2K |
|
753
Tenet Healthcare
THC
$21.5B
| $2.16M | 0.03% |
88,967
-614
| -0.7% | -$12.2K |
|
754
MGIC Investment
MTG
$6.33B
| $2.15M | 0.03% |
165,735
| – | – |
|
|
SEE
755
DELISTED
Sealed Air
SEE
| $2.15M | 0.03% |
50,369
-5,444
| -10% | -$246K |
|
|
SYNH
756
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.15M | 0.03% |
+60,685
| New | +$2.38M |
|
757
Cabot Corp
CBT
$4.45B
| $2.15M | 0.03% |
38,571
-625
| -2% | -$39.4K |
|
|
LM
758
DELISTED
Legg Mason, Inc.
LM
| $2.15M | 0.03% |
52,757
-1,341
| -2% | -$55.4K |
|
759
Jacobs Solutions
J
$16.8B
| $2.14M | 0.03% |
43,812
-1,250
| -3% | -$66.2K |
|
|
COR
760
DELISTED
Coresite Realty Corporation
COR
| $2.14M | 0.03% |
21,370
-264
| -1% | -$27K |
|
761
Compass Minerals
CMP
$1.1B
| $2.13M | 0.03% |
35,389
-1,983
| -5% | -$133K |
|
762
ScottsMiracle-Gro
SMG
$3.59B
| $2.13M | 0.03% |
24,867
-1,003
| -4% | -$95.5K |
|
|
EXAS
763
DELISTED
Exact Sciences
EXAS
| $2.11M | 0.02% |
52,309
-2,023
| -4% | -$98.7K |
|
|
BID
764
DELISTED
Sotheby's
BID
| $2.11M | 0.02% |
41,119
-341
| -0.8% | -$17.4K |
|
|
WRI
765
DELISTED
Weingarten Realty Investors
WRI
| $2.09M | 0.02% |
74,547
-1,016
| -1% | -$29.2K |
|
|
FLIR
766
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $2.09M | 0.02% |
41,806
-1,069
| -2% | -$53.2K |
|
|
ESL
767
DELISTED
Esterline Technologies
ESL
| $2.09M | 0.02% |
28,581
-373
| -1% | -$27.8K |
|
768
Hain Celestial
HAIN
$53.9M
| $2.08M | 0.02% |
64,850
-820
| -1% | -$29.8K |
|
769
Valmont Industries
VMI
$9.5B
| $2.07M | 0.02% |
14,162
-143
| -1% | -$22.4K |
|
770
Sarepta Therapeutics
SRPT
$1.95B
| $2.05M | 0.02% |
27,646
| – | – |
|
|
GAP
771
The Gap Inc
GAP
$7.34B
| $2.04M | 0.02% |
65,556
-1,820
| -3% | -$59.6K |
|
|
CSRA
772
DELISTED
CSRA Inc.
CSRA
| $2.03M | 0.02% |
49,331
-1,343
| -3% | -$49.3K |
|
773
Regal Rexnord
RRX
$11.4B
| $2.03M | 0.02% |
27,657
-375
| -1% | -$28.2K |
|
774
Cable One
CABO
$206M
| $2.01M | 0.02% |
2,928
-40
| -1% | -$28K |
|
775
Worthington Enterprises
WOR
$2.85B
| $2.01M | 0.02% |
75,918
-1,618
| -2% | -$45.4K |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q1 2018 Portfolio in Review
As of Q1 2018, MetLife Investment Management held 2,271 positions worth $8.49B, down 3.9% from $8.84B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
MetLife Investment Management's Q1 2018 filing shows 51 new, 125 increased, 935 reduced and 90 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M. The largest sale was Bank of New York Mellon, an estimated $17.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q1 2018 buy was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $25.3M increase.
- MetLife Investment Management's biggest Q1 2018 reduction was Apple, cutting an estimated $10.6M.
- MetLife Investment Management fully exited Bank of New York Mellon in Q1 2018, selling an estimated $17.1M.
- MetLife Investment Management's ten largest holdings make up 16% of its $8.49B portfolio in Q1 2018.
- MetLife Investment Management opened 51 new positions and closed 90 in Q1 2018.
- MetLife Investment Management's portfolio value fell 3.9% quarter-over-quarter to $8.49B.
Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.